SEC Form D · filed December 4, 2025
Odyssey Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (34)
Gary D. Glick · Boston, MAExec · DirectorCarl D. Gordon · Boston, MADirectorValerie D. Odegard · Boston, MADirectorJeffrey D. Leiden · Boston, MADirectorJill D. Carroll · Boston, MADirectorTimothy D. Walbert · Boston, MADirectorCarl D. Gordon · Boston, MADirectorTimothy D. Walbert · Boston, MADirectorJill D. Carroll · Boston, MADirectorJeffrey D. Leiden · Boston, MADirectorGary D. Glick · Boston, MAExec · DirectorValerie D. Odegard · Boston, MADirectorCarolyn F. Ng · Boston, CADirectorPaulina D. Hill · Boston, MADirectorNan D. Li · Boston, MADirectorJason F. Haas · Boston, MAExecNia F. Tatsis · Boston, MADirectorKsenija F. Pavletic · Boston, MADirectorShelley F. Chu · Boston, MADirectorLan F. Smith · Boston, MADirectorTravis C. Miller · Wilmington, DEDirectorJohn C. Gillam · Wilmington, DEExec · DirectorRoger K. Coit · Walnut Creek, CADirectorChristopher Mayer · Mt Airy, MDDirectorAdam Lilling · Venice, CADirectorDavid Grant · Plano, TXDirectorCarolyn F. Ng · Boston, CADirectorPaulina D. Hill · Boston, MADirectorNan D. Li · Boston, MADirectorJason F. Haas · Boston, MAExecNia F. Tatsis · Boston, MADirectorKsenija F. Pavletic · Boston, MADirectorShelley F. Chu · Boston, MADirectorLan F. Smith · Boston, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗